Rabbi Elliot Schrier Named Mara D’Atra of Bnai Yeshurun By Elizabeth Kratz | April 28, 2021
After an exhaustive 18-month rabbinic search and interview process, punctuated by a global pandemic, Rabbi Elliot Schrier was named mara d’atra of Teaneck’s Congregation Bnai Yeshurun (CBY). The role became available when Rabbi Steven Pruzansky announced plans to make aliyah in 2019, after more than a quarter century serving at the helm of Teaneck’s 530-families-strong shul. Rabbi Schrier will join the rabbinic team of Rabbi Ari Zahtz and Assistant Rabbi Yosef Weinberger.
Rabbi Schrier, who grew up in Woodmere, will complete his move to CBY late this summer as he winds up his rabbinic duties at the Albert Einstein Synagogue at the Albert Einstein College of Medicine in the Bronx, where he has served since 2016.
Press release content from PR Newswire. The AP news staff was not involved in its creation.
Eurofins Transplant Diagnostics Group Receives New York State CLEP Approval for Novel Rejection Biomarker Assays
April 27, 2021 GMT
Eurofins Transplant Diagnostics
LEE’S SUMMIT, Mo. and FRAMINGHAM, Mass., April 27, 2021 /PRNewswire/ Eurofins Viracor, one of the largest and most recognized infectious diseases testing laboratories in the United States, and Transplant Genomics, the trusted global partner in precision biomarkers for the transplant community innovating to improve patient outcomes, announce that the New York State Department of Health Clinical Laboratory Evaluation Program (CLEP) has approved the Viracor TRAC™ (Transplant Allograft Rejection Check) donor-derived cell-free DNA test and TruGraf® blood gene expression test, both of which help healthcare providers assess rejection status in kidney transplant recipients.
Why Companies Are Betting Big On Psychedelic Drugs To Treat Mental Health Epidemic
- Financialnewsmedia.com News Commentary
Share this article
Share this article
PALM BEACH, Fla., April 28, 2021 /PRNewswire/ Psychedelic medicine is having a moment. Once dismissed as a party drug for its hallucinogenic effects, ketamine is emerging as a novel alternative treatment for depression. For most, psychedelic drugs conjure up images of the 1960 s, hippies tripping out on LSD or magic mushrooms. However, early studies are finding that psilocybin – the active agent in magic mushrooms – could treat addiction, depression, anxiety and mental health conditions like post-traumatic stress disorder (PTSD). Similarly, cancer patients with painful anxiety over their illness have found more peaceful acceptance after participating in a study that involved intensive therapy and being given a drug that was once a symbol of the 60 s counterculture. Last year, the US Food and Drug Administrati
How Long Can We Live?
https://www.nytimes.com/2021/04/28/magazine/human-lifespan.html
Credit.Photo illustration by Maurizio Cattelan and Pierpaolo Ferrari
Sections
How Long Can We Live?
New research is intensifying the debate with profound implications for the future of the planet.
Credit.Photo illustration by Maurizio Cattelan and Pierpaolo Ferrari
Listen to This ArticleAudio Recording by Audm
To hear more audio stories from publications like The New York Times,
.
In 1990, not long after Jean-Marie Robine and Michel Allard began conducting a nationwide study of French centenarians, one of their software programs spat out an error message. An individual in the study was marked as 115 years old, a number outside the program’s range of acceptable age values. They called their collaborators in Arles, where the subject lived, and asked them to double-check the information they had provided, recalls Allard, who was then the director of the IPSEN Foundation, a nonprofit rese